First Affiliated Hospital, Sun Yat-sen University

This study tested a computer model designed to help surgeons make better decisions for patients with a complex type of liver cancer that has spread into the bile duct. The tool analyzed patient scans and health data to predict who would live longer if surgeons removed the bile du…

This study tested a combination of three treatments for people with colorectal cancer that had spread to the liver and was no longer responding to standard chemotherapy. The goal was to see if using a targeted drug (regorafenib) along with two minimally invasive procedures that d…

This study looked back at medical records of 129 patients with intermediate-to-advanced liver cancer who underwent a common treatment called TACE. Researchers compared two different approaches to managing pain after the procedure: one group received a planned combination of pain …

This study looked back at past patient records to see if a specific feature seen on a CT scan (called radiographic microvascular invasion) can predict how well patients with intermediate-stage liver cancer will respond to treatment. It compared patients who received a standard pr…

This study looked at whether doctors could use MRI scans and artificial intelligence (AI) to predict how patients with a specific type of liver cancer (intrahepatic cholangiocarcinoma) would fare after surgery. Researchers analyzed MRI scans from 169 patients to see if certain fe…

This study looked back at medical records and scans from 3,000 patients with advanced liver cancer who could not have surgery. Researchers used artificial intelligence (AI) to analyze their pre-treatment scans, trying to find patterns that predict whether a patient would live lon…